|
Market Closed -
Other stock markets
|
Pre-market 06:46:02 am | |||
| 100.89 USD | -1.35% |
|
100.78 | -0.11% |
| Dec. 04 | Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case -- Update | DJ |
| Dec. 04 | Halozyme Wins German Patent Injunction Blocking Merck's Subcutaneous Keytruda | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | $105.92 | +4.99% | 26 | ||||||
| $1,056.7 | +4.16% | 27 | ||||||
| $202.54 | +0.03% | 24 | ||||||
| $243.55 | +6.49% | 29 | ||||||
| CHF 311.78 | +0.54% | 18 | ||||||
| GBX 197.15 | +9.26% | 19 | ||||||
| CHF 131.65 | -1.22% | 19 | ||||||
| DKK 398.34 | +30.26% | 20 | ||||||
| $324.25 | -4.68% | 27 | ||||||
| $130.63 | +6.54% | 25 | ||||||
| $29.04 | +12.99% | 24 | ||||||
| €106.13 | +25.49% | 22 | ||||||
| $485.36 | +6.12% | 25 | ||||||
| $53.41 | +2.81% | 22 | ||||||
| GBX 18.33 | +0.39% | 18 | ||||||
| ¥8,623.33 | +1.79% | 15 | ||||||
| $492.17 | +5.77% | 24 | ||||||
| CN¥81.04 | +32.3% | 18 | ||||||
| ¥4,923.07 | +10.06% | 15 | ||||||
| Average | 942.86 | +8.11% | 22 | ||||||
| Weighted average by Cap. | 617.06 | +5.93% | 24 |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
